The Chinese government's policies promoting opening up and innovation, as well as the excellent business environment it fosters for foreign enterprises, have injected strong confidence into Sanofi's ...

The divestiture of the Czech facility follows US-based Novavax's licensing deal worth at least $1.2 billion with French ...

COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker ...

COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker ...

French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in ...

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

Health-care companies ticked down, but remained near all-time highs, amid promising drug developments in the biotech niche. Janux Therapeutics stock surged after the California biotech concern's ...

JPMorgan raised the firm’s price target on Sanofi (SNY) to EUR 105 from EUR 100 and keeps a Neutral rating on the shares.Don't Miss our Black ...

MeiraGTx Holdings plc sees a stock surge after positive Parkinson's disease data and strategic partnerships, showing growth ...

Pharma vs pushes back as Senators look into telehealth moves, startups using AI for small molecule drugs, and more.

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in ...